|
KR101752476B1
|
|
A process for purifying procyanidins from extract of Lindera obtusiloba Blume
|
|
KR20170101724A
|
|
Use of Substituted N-(pyrrolidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amines as Janus kinase inhibitor
|
|
KR101751516B1
|
|
Combined liquid pharmaceutical composition comprising stabilized dried powder of herbal medicine
|
|
KR20170022803A
|
|
Janus kinase 1 selective inhibitors and their pharmaceutical use
|
|
KR20160081359A
|
|
A pharmaceutical composition for treating or preventing respiratory disease comprising combined herbal extracts
|
|
KR20130102515A
|
|
Tablet-type compositions of sweetner and production method thereof
|
|
KR20120093461A
|
|
Tablet-type compositions of sweetner and production method thereof
|
|
KR20120038035A
|
|
Pharmaceutical compositions comprising anti-asthmatic 3-aminopyrrolidine derivatives
|
|
KR20110112711A
|
|
Method for preparing and purifying of glyceryl monooleate
|
|
KR20100002239A
|
|
Composition comprising the extracts of leaves of lindera obtusiloba for prevention and treatment of cardiovascular diseases
|
|
KR20110005532A
|
|
Piperazinylethyl 3-aminopyrrolidine derivatives as ccr2 antagonists
|
|
KR20100076180A
|
|
3-aminopyrrolidine derivatives as ccr2 antagonists
|
|
KR20090079650A
|
|
Composition Comprising the Extracts of Lysimachia clethroides for Prevention and Treatment of Cardiovascular Diseases
|
|
KR20090079584A
|
|
Composition Comprising the Extracts of Lindera obtusiloba for Prevention and Treatment of Cardiovascular Diseases
|
|
KR100834348B1
|
|
Composition comprising the extracts of dictyota coriaceum for prevention and treatment of cardiovascular dyscrasia
|
|
CN1473160A
|
|
Indole derivatives as medicinal compositions for antifungal and/or antiparasitic agents
|
|
KR20020074568A
|
|
3-Arylisoquinoline derivatives and salt thereof useful for antitumor agents
|
